Implementing the Kidney Disease: Improving Global Outcomes/acute kidney injury guidelines in ICU patients

Current Opinion in Critical Care

Volumn 19, Issue 6, 2013, Pages 544-553

  Hoste, Eric A J ^a,b   De Corte, Wouter ^c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

^c AZ GROENINGE   (Belgium)

Author keywords

acute kidney injury; clinical practice guidelines; contrast associated acute kidney injury; intensive care unit; renal replacement therapy 2013 Wolters Kluwer Health | Lippincott Williams Wilkins.

Indexed keywords

ACETIC ACID; ACETYLCYSTEINE; ALBUMIN; AMINOGLYCOSIDE; AMPHOTERICIN B; ARGATROBAN; BICARBONATE; CALCIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; CONTRAST MEDIUM; CREATININE; DANAPAROID; DIURETIC AGENT; DOPAMINE; ECHINOCANDIN; ERYTHROPOIETIN; FENOLDOPAM; FONDAPARINUX; GLUCOSE; HEPARIN; HETASTARCH; INSULIN; ISOTONIC SOLUTION; LOW MOLECULAR WEIGHT HEPARIN; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; PROTAMINE; SODIUM CHLORIDE; THEOPHYLLINE;

ACUTE KIDNEY FAILURE; ANTICOAGULANT THERAPY; BLOOD PRESSURE REGULATION; CALORIC INTAKE; CONTINUOUS HEMOFILTRATION; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MONITORING; FLUID RESUSCITATION; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HUMAN; HYDRATION; HYPERVOLEMIA; INSULIN TREATMENT; INTENSIVE CARE; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; LONG TERM CARE; MORTALITY; NEPHROTOXICITY; NUTRITIONAL SUPPORT; OXYGENATION; PRACTICE GUIDELINE; PROTEIN INTAKE; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION; TREATMENT OUTCOME; URINARY CATHETER; URINE VOLUME; VASCULAR ACCESS;

ACUTE KIDNEY INJURY; FEMALE; HEMODYNAMICS; HEMOFILTRATION; HUMANS; INTENSIVE CARE; ISOTONIC SOLUTIONS; MALE; NEPHROLOGY; PRACTICE GUIDELINES AS TOPIC; RENAL REPLACEMENT THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888186035     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000039     Document Type: Review

References (91)

1. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212
2. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31
3. Kidney disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012; 2:1-138
4. Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med 2008; 36:S146-S151 (Pubitemid 351483044)
5. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10:R73
6. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007; 35:1837-1843 (Pubitemid 47220356)
7. Joannidis M, Metnitz B, Bauer P, et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009; 35:1692-1702
8. Mandelbaum T, Scott DJ, Lee J, et al. Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria. Crit Care Med 2011; 39:2659-2664
9. Metnitz PG, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30:2051-2058
10. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294:813-818 (Pubitemid 41175724)
11. Nisula S, Kaukonen KM, Vaara ST, et al. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med 2013; 39:420-428
12. Bagshaw SM, George C, Bellomo R. Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 2007; 11:R68
13. Waikar SS, Curhan GC, Wald R, et al. Declining mortality in patients with acute renal failure, 1998 to 2002. J Am Soc Nephrol 2006; 17:1143-1150
14. Mehta RL, McDonald B, Gabbai F, et al. Nephrology consultation in acute renal failure: does timing matter? Am J Med 2002; 113:456-461 (Pubitemid 35335796)
15. Perez-Valdivieso JR, Bes-Rastrollo M, Monedero P, et al. Prognosis and serum creatinine levels in acute renal failure at the time of nephrology consultation: an observational cohort study. BMC Nephrol 2007; 8:14
16. Balasubramanian G, Al-Aly Z, Moiz A, et al. Early nephrologist involvement in hospital-acquired acute kidney injury: a pilot study. Am J Kidney Dis 2011; 57:228-234
17. Ponce D, Zorzenon CD, Santos NY, Balbi AL. Early nephrology consultation can have impact on outcome of acute kidney injury patients. Nephrol Dial Transplant 2011; 26:3202-3206
18. Meier P, Bonfils RM, Vogt B, et al. Referral patterns and outcomes in noncritically ill patients with hospital-acquired acute kidney injury. Clin J Am Soc Nephrol 2011; 6:2215-2225
19. Colpaert K, Hoste EA, Steurbaut K, et al. Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med 2012; 40:1164-1170
20. Hoste EA, Cruz DN, Davenport A, et al. The epidemiology of cardiac surgeryassociated acute kidney injury. Int J Artif Organs 2008; 31:158-165 (Pubitemid 351425013)
21. Zavada J, Hoste E, Cartin-Ceba R, et al. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant 2010; 25:3911-3918
22. Siew ED, Peterson JF, Eden SK, et al. Use of multiple imputation method to improve estimation of missing baseline serum creatinine in acute kidney injury research. Clin J Am Soc Nephrol 2013; 8:10-18
23. Macedo E, Malhotra R, Claure-Del Granado R, et al. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2011; 26:509-515
24. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36:222-231
25. OGrady NP, Alexander M, Burns LA, et al. Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52:1087-1099
26. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
27. Schabinski F, Oishi J, Tuche F, et al. Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 2009; 35:1539-1547
28. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.4 versus ringers acetate in severe sepsis. N Engl J Med 2012; 367:124-134
29. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911
30. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013; 309:678-688
31. Patel A, Waheed U, Brett SJ. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 2013; 39:811-822
32. Gattas DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013; 39:558-568
33. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256 (Pubitemid 38669207)
34. Payen D, de Pont A, Sakr Y, et al., and the Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; 12:R74
35. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009; 76:422-427
36. Vaara ST, Korhonen A-M, Kaukonen K-M, et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care 2012; 16:R197
37. Teixeira C, Garzotto F, Piccinni P, et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013; 17:R14
38. Grams ME, Estrella MM, Coresh J, et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6:966-973
39. Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255:821-829
40. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308:1566-1572
41. Murugan R, Kellum JA. Fluid balance and outcome in acute kidney injury: is fluid really the best medicine? Crit Care Med 2012; 40:1970-1972
42. Di Giantomasso D, Bellomo R, May CN. The haemodynamic and metabolic effects of epinephrine in experimental hyperdynamic septic shock. Intensive Care Med 2005; 31:454-462
43. Di Giantomasso D, Morimatsu H, May CN, Bellomo R. Intrarenal blood flow distribution in hyperdynamic septic shock: effect of norepinephrine. Crit Care Med 2003; 31:2509-2513 (Pubitemid 37281736)
44. Albanese J, Leone M, Garnier F, et al. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004; 126:534-539 (Pubitemid 39093440)
45. Badin J, Boulain T, Ehrmann S, et al. Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study. Crit Care 2011; 15:R135
46. Brienza N, Giglio MT, Marucci M, Fiore T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 2009; 37:2079-2090
47. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
48. Lin SM, Huang CD, Lin HC, et al. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 2006; 26:551-557
49. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
50. Van den BergheG, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461 (Pubitemid 43200296)
51. Schetz M, Vanhorebeek I, Wouters PJ, et al. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 2008; 19:571-578 (Pubitemid 351355400)
52. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297
53. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180:821-827
54. Ho KM, Sheridan DJ.Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006; 333:420
55. Karajala V, Mansour W, J.A. K. Diuretics in acute kidney injury. Minerva Anestesiol 2009; 75:241-247
56. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356:2139-2143 (Pubitemid 32047951)
57. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142:510-524
58. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001; 29:1526-1531 (Pubitemid 32762331)
59. Tasanarong A, Duangchana S, Sumransurp S, et al. Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase- associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrol 2013; 14:136
60. Oh SW, Chin HJ, Chae DW, Na KY. Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting. J Korean Med Sci 2012; 27:506-511
61. Song YR, Lee T, You SJ, et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 2009; 30:253-260
62. de Seigneux S, Ponte B, Weiss L, et al. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol 2012; 13:132
63. Endre ZH, Walker RJ, Pickering JW, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010; 77:1020-1030
64. Hoste EA, Doom S, De Waele J, et al. Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 2011; 3727:1921-1931
65. Valette X, Parienti JJ, Plaud B, et al. Incidence, morbidity, and mortality of contrast-induced acute kidney injury in a surgical intensive care unit: a prospective cohort study. J Crit Care 2012; 27:322
66. Lakhal K, Ehrmann S, Chaari A, et al. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care 2011; 26:593-599
67. Rashid AH, Brieva JL, Stokes B. Incidence of contrast-induced nephropathy in intensive care patients undergoing computerised tomography and prevalence of risk factors. Anaesth Intensive Care 2009; 37:968-975
68. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51:1419-1428 (Pubitemid 351471786)
69. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291:2328-2334 (Pubitemid 38656299)
70. Hoste EA, De Waele JJ, Gevaert SA, et al. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and metaanalysis. Nephrol Dial Transplant 2010; 25:747-758
71. Zoungas S, Ninomiya T, Huxley R, et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009; 151:631-638
72. Jang J-S, Jin H-Y, Seo J-S, et al. Sodium bicarbonate therapy for the 73.
73. Palevsky PM, Baldwin I, Davenport A, et al. Renal replacement therapy and the kidney: minimizing the impact of renal replacement therapy on recovery of acute renal failure. Curr Opin Crit Care 2005; 11:548-554 (Pubitemid 41697326)
74. Waikar SS, Bonventre JV. Can we rely on blood urea nitrogen as a biomarker to determine when to initiate dialysis? Clin J Am Soc Nephrol 2006; 1:903-904
75. Bagshaw SM, Uchino S, Bellomo R, et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009; 24:129-140
76. Ostermann M, Chang R. Correlation between parameters at initiation of renal replacement therapy and outcome in patients with acute kidney injury. Crit Care 2009; 13:R175
77. De Corte W, Vanholder R, Dhondt AW, et al. Serum urea concentration is probably not related to outcome in ICU patients with AKI and renal replacement therapy. Nephrol Dial Transplant 2011; 26:3211-3218
78. Bellomo R, Lipcsey M, Calzavacca P, et al. Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis. Intensive Care Med 2013; 39:429-436
79. Bellomo R, Cass A, Cole L, et al. An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med 2012; 40:1753-1760
80. Fealy N, Baldwin I, Johnstone M, et al. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration. Int J Artif Organs 2007; 30:301-307 (Pubitemid 46938854)
81. Hetzel GR, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011; 26:232-239
82. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67:2361-2367 (Pubitemid 41623398)
83. Monchi M, Berghmans D, Ledoux D, et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004; 30:260-265 (Pubitemid 38253417)
84. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 37:545-552
85. Cimochowski GE, Worley E, Rutherford WE, et al. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 1990; 54:154-161 (Pubitemid 20019577)
86. Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 1991; 6:722-724
87. Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007; CD003773
88. Schneider AG, Bellomo R, Bagshaw SM, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 2013; 39:987-997
89. Bagshaw SM, Bellomo R, Devarajan P, et al. Review article: acute kidney injury in critical illness. Can J Anaesth 2010; 57:985-998
90. Palevsky PM, Zhang JH, OConnor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359:7-20 (Pubitemid 351931092)
91. Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361:1627-1638